Golimumab Subcutaneous and Hydromorphone Extended-Release Tablets
Determining the interaction of Golimumab Subcutaneous and Hydromorphone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: hydromorphone
Brand name: Dilaudid, Exalgo, Hydrostat IR, Dilaudid-HP
Synonyms: Hydromorphone, HYDROmorphone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Hydromorphone Hydrochloride
- Golimumab Subcutaneous-Hydromorphone injection
- Golimumab Subcutaneous-Hydromorphone Liquid
- Golimumab Subcutaneous-Hydromorphone rectal
- Golimumab Subcutaneous-Hydromorphone Suppository
- Golimumab Subcutaneous-Hydromorphone Tablets
- Hydromorphone Extended-Release Tablets-GoLYTELY
- Hydromorphone Extended-Release Tablets-Gonadorelin
- Hydromorphone Extended-Release Tablets-Gonadorelin Intravenous, Injection
- Hydromorphone Extended-Release Tablets-Gonadotropin, Chorionic
- Hydromorphone Extended-Release Tablets-Gonal-F
- Hydromorphone Extended-Release Tablets-Gonal-f RFF